Department of Pathology News

Repairing nerve cell damage from multiple sclerosis

Tuesday, June 17, 2014

Dr. Bridget-Shafit Zagardo investigates how to repair nerve cell damage from multiple sclerosis.

Each year multiple sclerosis (MS) strikes millions of young adults in the United States and worldwide, limiting their mobility, causing disability and pain, and seriously affecting their quality of life. Onset is observed in young adults in their 20's and 30's, with a pediatric form of MS becoming increasingly prevalent. While various current treatments delay progression or manage the symptoms, there is currently no cure and there is significant decline over a 15-20 year period with a large number of patients progressing from a relapsing remitting disease course to a progressive disease course.

For over 30 years, Einstein Pathology researcher Bridget Shafit-Zagardo, PhD, has worked to understand MS and give people suffering from the neurological disease hope.

“We’re predominantly interested in enhancing repair and functional recovery following central nervous system (CNS) injury,” said Dr. Shafit-Zagardo, a professor of pathology, who joined Einstein in 1984.

Enhancing repair

She explained that MS damages neurons, or nerve cells, and the myelin sheath - the insulation that surrounds and protects axons. The loss of myelin – demyelination - interferes with the transmission of normal nerve conductance required for nerves to signal between the brain, spinal cord and the rest of the body. 

“The goal is to repair axonal damage and enhance remyelination,” she said, noting that the current treatments address inflammation, but do not address nerve cell repair.

The exact antigen — or target that the immune cells are sensitized to attack — remains unknown, which is why MS is considered by many experts to be "immune-mediated," she said.

Abnormally hyper-activated infiltrating immune cells cross the blood brain barrier and induce inflammation in the CNS. As a result, resident cells of the CNS become activated and secrete inflammatory molecules that further enhance inflammation resulting in damage to neurons and oligodendrocytes, the myelin-synthesizing cells of the CNS. Axonal damage, destruction of myelin and activation of astrocytes called astrogliosis, ultimately result in CNS lesions referred to as glial scars or plaques in areas of damage. The resulting insult affects nerve fibers producing symptoms that may affect vision, coordination and mobility, and continence, among other symptoms.  

To that end, Dr. Shafit-Zagardo and her team are investigating strategies to slow the progression of axonal damage and demyelination and to enhance remyelination.

“Until damaged myelin and cell debris resulting from inflammation are cleared, you do not have efficient repair and recovery cannot occur,” said Dr. Shafit-Zagardo. The lab’s ongoing projects include applying techniques of molecular & cell biology, biochemistry, immunocytochemistry, confocal and electron microscopy to address questions concerning the structure, function and regulation of myelination in the normal CNS and remyelination following neuroimmune injury.

Identifying signaling pathways

Central to the treatment of MS is how cell signaling pathways regulate oligodendrocyte cell survival and remyelination after the inflammatory response.
Toward this goal, the lab has used molecular approaches to identify several genes implicated in signaling pathways that regulate oligodendrocytes and protect against demyelination. Among those genes identified were members of the Tyro3/Axl/Mer (TAM) family of receptor tyrosine kinases. As Dr. Shafit-Zagardo explained, to clear debris in MS lesions, the ligand or growth factor binds to receptors on the cell and signals downstream, recruiting signaling molecules that are protective for survival of the cell and also serve to activate other signaling pathways necessary for repair. The lab has demonstrated that signaling through the growth arrest-specific protein 6 (Gas6)/TAM pathway protects oligodendrocytes against injury.

Dr. Shafit-Zagardo’s research is funded by grants from the National Multiple Sclerosis Society and the National Institute of Neurological Disorders and Stroke. Assisting Dr. Shafit-Zagardo in her research is postdoctoral fellow Ross Gruber, graduate student Alex Ray and technician Kathleen O’Guin. Ross and Alex have been generating different mouse models, including single and double knockout mice that can be used to study different signaling pathways.

Moving forward

Despite her many achievements both inside and outside of science, the Bronx native has not had to venture far. After earning her master’s degree in biology at New York University, she studied human genetics with Dr. Robert Desnick and was awarded a PhD from City University of New York/ Mount Sinai School of Medicine, where her research focused on lysosomal storage diseases focusing on Gaucher’s disease. She initially joined Einstein as a postdoctoral research fellow under the mentorship of Dr. Joseph Maio in Cell Biology, working on long interspersed repetitive sequences. Dr. Shafit-Zagardo became involved in MS after seeing that early developmental genes could be turned back on during remyelination, and continued to expand on those initial studies.

MS research has come a long way in the last two decades. “Thirty years ago, there were no real treatments,” Dr. Shafit-Zagardo said, noting that the last 20 years has seen a variety of medications used for MS to block inflammation, but they do not target myelin repair.

Moving forward, her lab will continue to work toward developing better treatment and attempt to attempt to find factors that can aid in repair. She said, “Once we’ve determined how signaling occurs we will be able to use this information to protect against further damage."

Recent News

brochure 2016 Pathology Research Retreat
On Wednesday, June 8, 2016, the Department of Pathology hosted its annual Research Retreat, a day-long event highlighting the outstanding work of students, postdocs, residents and fellows.

gift bags Bidding Farewell to Pathology Residents and Fellows
On Thursday, June 1, 2016, the Department of Pathology bid farewell to 13 outstanding residents and fellows at a graduation dinner held in their honor at the Westchester Country Club, in Rye, New York.

SabineEliminating Barriers to Healthcare in the Bronx
Over 30 women from the Bronx with little or no health insurance participated in the recent See Test & Treat event, a free cervical and breast cancer screening program, held at the Montefiore Imaging Center on Saturday, May 14, 2016.

Christine McMahon jpg The Department of Pathology mourns the loss of Dr. Christine McMahon
The Department of Pathology mourns the loss of Dr. Christine McMahon, esteemed colleague and renowned hematopathologist.

Lab week 2 Celebrating Montefiore's Laboratory Professionals
Hematology laboratory technologist Vera Maliarov is among the pathology department's 700 specialized laboratory medical professionals that help process over 5,000 specimens per day at Montefiore. In honor of National Medical Laboratory Professionals Week, the department recognized the important role these experts play in supporting their colleagues and positively impacting the lives of countless patients throughout the MMC community.

Lucia WolgastBeyond-Ebola: Preparing For Highly Infectious Diseases at Montefiore
When it comes to preventing the spread of infectious diseases in a large hospital setting, it takes a team of highly-trained health care workers to provide a safe environment. Montefiore Medical Center’s legion of dedicated pathologists and technologists are responsible for safely processing the infectious pathogens in the laboratories.

Laura SantambrogioEinstein-Montefiore Researchers Identify Protein that Triggers Autoimmune Reaction in Juvenile Idiopathic Arthritis Patients
Einstein-Montefiore researchers have identified the protein in the human body that may trigger an autoimmune response responsible for the most common form of juvenile arthritis.

pullmanA New Light Could Diagnose Kidney Disease Faster
A new super-resolution microscope could enable doctors to diagnose kidney diseases earlier and faster - and for less cost. The discovery, made by researchers in the Department of Pathology at Montefiore Medical Center and Albert Einstein College of Medicine, in collaboration with physicists at the University of St. Andrews, in Scotland, UK, has led to a new method for diagnosing nephrotic syndrome in the kidney

Mahalia DessruisseauxMalaria: Progress and Promise
From the lab to the field, Drs. Mahalia Desruisseaux and Kami Kim are among the Einstein-Montefiore scientists that are actively seeking new treatments for the deadly mosquito-borne illness—with a special focus on cerebral malaria.

KHRameshCytoGenomics Director Honored at Global Cancer Summit
K.H. Ramesh, PhD, ABMGG, FACMGG, was recently honored as a panel chair and keynote speaker at the Global Cancer Summit 2015: An International Collaborative Conference, held November 19-20, in Bangalore, India.  Dr. Ramesh, Director of Cancer CytoGenomics at Montefiore Medical Center and Associate Professor of Pathology at Einstein, presented and discussed “HER2 Genetic Heterogeneity and Fluorescence In Situ Hybridization Analysis in Invasive Ductal Breast Cancer.” The conference, which was held in memory of Senator M. Edward Kennedy, was attended by 700 delegates from 30 countries. 

Rachel HazanEinstein-Montefiore Breast Cancer Researchers Awarded Avon Foundation Grant
Rachel Hazan, PhD, and Susan Fineberg, MD, were awarded a grant from the Avon Foundation for Women to facilitate their collaborative study on the role of cell cycle inhibitor P21 in triple negative breast cancer, in primary tumors and in the metastatic setting.

tomitaReeling in the Structure of a Ubiquitous Parasite 
Postdoctoral researcher Tadakimi Tomita was raised on a mushroom farm in Japan; his love for nature inspired his research and passion for science. Working in the laboratory of Dr. Louis Weiss, Dr. Tomita discovered and characterized a novel glycoprotein responsible for structural integrity of the Toxoplasma gondii cell wall.  

Veenstra On Science, Life, and Love in New York City
Mike Veenstra, a Dutch PhD student in Dr. Joan Berman's lab, was interviewed last month by Oost TV as part of a series on people from the Overijssel region of the Netherlands who currently work and live in New York City. In this series, Mike discusses (in Dutch) his science, life in NYC - and what first brought him to the United States. Although the interview was conducted in Dutch - without subtitles - we’ve loosely summarized the video. Please take a look here.

Michael PrystowskySee Test & Treat: Free Cancer Screenings for Underserved Women
A team of Montefiore pathologists and clinicians from the departments of Obstetrics & Gynecology and Radiology provided free cervical and breast cancer screenings recently to over 40 underserved women ages 21 to 64 at the annual See Test & Treat® program, held at Montefiore Advanced Imaging, part of the Moses Division of Montefiore Medical Center in the Bronx.

Michael PrystowskyInspiring the Next Generation of Pathologists
The Pathologist magazine interviews Dr. Michael Prystowsky about his career, heading up one of the busiest pathology services in the US, and how pathologists can demonstrate their value.

Tiffany HebertMontefiore Pathologist Focuses on Training to Improve Testing Access in Rwanda.
Podcast: The College of American Pathologists (CAP) interviews Dr. Tiffany Hebert on her experience training a Rwandan physician to perform pathology testing services as part of a comprehensive program to improve screening methods and reduce the number of Rwandan women who die from HIV-related cancers.


Advancing NeuroAIDS Research

Einstein Graduate Dionna Williams, PhD, is heading to Johns Hopkins for a postdoctoral fellowship to further investigate NeuroAIDS. Full story 



Experimental pathology aims to define disease in terms of fundamental molecular and cellular processes. Research in our Department is focused on critical issues in multiple disease classes. Areas of focus include 

Research in each of these areas is highly interactive, and the Department strives for a collegial atmosphere in which collaborations can flourish. This effort is conducted through a variety of department-level activities, including regular meetings to discuss work in progress and a departmental retreat at which students, postdoctoral fellows, residents and faculty all have opportunity to present and discuss their research.

Research Funding Program

The Department of Pathology has established a research funding program to encourage residents and fellows to participate in clinical pilot research projects. Up to $2,000 will be awarded per research project, for projects of up to two years in duration.

Research Faculty

Amanda Beck, DVM 

Geoffrey Childs, PhD 

Joan W. Berman, PhD 

Mahalia Desruisseaux, MD, PhD 

Amy Fox, MD  

David Fooksman, PhD  

Rachel Hazan, PhD 

Lawrence Herbst, DVM, PhD 

Huan Huang, MD 

Sunhee C. Lee, MD  

Fernando Macian, MD, PhD 

Maja Oktay, MD, PhD 

Harry Ostrer, MD 

Thomas J. Ow, MD 

Michael B. Prystowsky, MD, PhD 

Moshe Sadofsky, MD, PhD 

Laura Santambrogio, MD, PhD 

Bridget Shafit-Zagardo, PhD 

Herbert Tanowitz, MD 

Louis Weiss, MD 

Click here to log in